Skip to content
MarketScale
‹ Back to Industries

Healthcare

Behind the Clinical Trials for Non-Alcohol Fatty Liver Disease that Can Benefit 30% of Americans

The Impact Research Institute (IRI) is Waco, Texas’ resource for extending care options for NAFLD (non-alcohol fatty liver disease.) Nadege Gunn is IRI’s Medical Director and President. She joined Kevin Stevenson on I Don’t Care to discuss her and her team’s mission to treat NAFLD and other related diseases and conditions. Dr. Gunn is…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

Share

The Impact Research Institute (IRI) is Waco, Texas’ resource for extending care options for NAFLD (non-alcohol fatty liver disease.) Nadege Gunn is IRI’s Medical Director and President. She joined Kevin Stevenson on I Don’t Care to discuss her and her team’s mission to treat NAFLD and other related diseases and conditions.

Dr. Gunn is a Gastroenterologist and Hepatologist whose main passion is the liver. “The liver is an amazing organ,” Dr. Gunn said. “It’s the only organ in the body that you could cut in half, and it can grow back in full size in about three months. The work we do in transplantation and replacing the liver is quite amazing, so that’s why I chose the field in general.”

Dr. Gunn helped open IRI in July of 2021. Necessity created the decision to develop the center. While practicing clinical trials in Austin, Texas, Dr. Gunn saw many patients traveling from the Waco area to receive treatment options for NAFLD. With no scan or clinical trial options available to people in Waco and the surrounding area, Dr. Gunn recognized an opportunity to open a clinic to serve the growing needs.

Community outreach is critical to the clinic’s role in Waco, TX. When they identify candidates who may have NAFLD, they do a non-invasive scan at the center to determine if the candidate does have the disease. “If they do, then we invite them to maybe participate in a clinical trial because there are no treatments for fatty liver,” Dr. Gunn said.

For people wondering if they might have NAFLD, Dr. Gunn said the disease is often asymptomatic in the early stages. “It is when the disease is progressing, when it is starting to injure and harm the liver, that people might start firstly feeling fatigued,” Dr. Gunn said. “They might feel pain in the right upper quadrant of their abdomen and their belly.” Recognizing these warning signs and seeking a diagnosis is critical before full-on cirrhosis of the liver occurs.

More Like This Story:

Providing Real-Time Feedback for Virtual Health

Tearing Down the Barrier of Prior Authorization Through Automation

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel →

New to MarketScale?

MarketScale is the platform Healthcare companies use to turn their own experts into content like this. Want the short overview?

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

How Do You Work Around Hospital Operations?

How Do You Work Around Hospital Operations?

The article discusses the unique challenges of conducting restoration or renovation work in hospitals without disrupting their essential operations. This requires meticulous planning and execution to ensure that patient care and facility access remain uninterrupted. The primary goal of such projects is to maintain hospital functionality while completing the necessary work.

  • 01Hospitals must maintain operations during renovations.
  • 02Patient care and staff access are top priorities.
  • 03Projects require extensive planning to minimize disruption.

Jun 26, 2026

Digital healthcare's four pillars: how hardware, software, platforms, and enablers are reshaping medicine

Digital healthcare's four pillars: how hardware, software, platforms, and enablers are reshaping medicine

Digital healthcare is being transformed by four key sectors: hardware, software, platforms, and enablers. These sectors are driving global investment and changing the way care is delivered, from AI diagnostics to electroceuticals. The integration of these technologies is essential for the evolution of modern medicine.

  • 01Digital healthcare is shaped by four core sectors: hardware, software, platforms, and enablers.
  • 02Investment in digital health technologies is increasing globally.
  • 03Technologies like AI diagnostics and electroceuticals are changing care delivery.

Jun 26, 2026

Health tech's next phase: AI partnerships, virtual care wins, and the push for real interoperability

Health tech's next phase: AI partnerships, virtual care wins, and the push for real interoperability

The healthcare technology industry is evolving significantly, characterized by advancements in AI partnerships and virtual care solutions. The sector is also responding to CMS mandates for real interoperability in mid-2026. Execution is the key theme as businesses leverage technology to improve healthcare delivery.

  • 01AI partnerships are transforming healthcare processes.
  • 02Virtual care solutions are showing significant benefits.
  • 03Compliance with CMS interoperability mandates is crucial.

Jun 23, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub